The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis
暂无分享,去创建一个
Dominique Thabut | Y. Ngo | D. Thabut | J. Albrecht | T. Poynard | V. Ratziu | M. Munteanu | F. Charlotte | S. Naveau | D. Messous | D. Capron | A. Abella | J. Massard | A. Mercadier | M. Manns | Thierry Poynard | Vlad Ratziu | Sylvie Naveau | Djamila Messous | Mona Munteanu | Frederic Charlotte | Yen Ngo | Dominique Capron | Annie Abella | Julien Massard | Anne Mercadier | Michael Manns | Janice Albrecht
[1] V. de Lédinghen,et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease , 2006, BMC gastroenterology.
[2] P. Giral,et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.
[3] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[4] D. Thabut,et al. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. , 2005, Clinical Gastroenterology and Hepatology.
[5] Jimmy D Bell,et al. Oesophageal ulceration: more than meets the naked eye? , 2004, Gut.
[6] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[7] F. Negro,et al. Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C. , 2004, Journal of hepatology.
[8] D. Thabut,et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C , 2004, Comparative hepatology.
[9] D. Thabut,et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. , 2004, Clinical chemistry.
[10] J. Levitsky,et al. Diagnosis and therapy of alcoholic liver disease. , 2004, Seminars in liver disease.
[11] A. McCullough,et al. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.
[12] N. Scopinaro,et al. Liver Damage in Severely Obese Patients: a Clinical-Biochemical-Morphologic Study on 1,000 Liver Biopsies , 2004, Obesity surgery.
[13] N. Afdhal. Biopsy or biomarkers: is there a gold standard for diagnosis of liver fibrosis? , 2004, Clinical chemistry.
[14] J. Horton,et al. Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.
[15] D. Thabut,et al. Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest) , 2004, Comparative hepatology.
[16] I. de Sio,et al. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[17] C. Mottin,et al. The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients , 2004, Obesity surgery.
[18] P Christoffersen,et al. Long term prognosis of fatty liver: risk of chronic liver disease and death , 2004, Gut.
[19] R. Contreras,et al. Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics , 2004, Nature Medicine.
[20] H. El‐Serag,et al. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.
[21] I. Wanless,et al. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. , 2004, Seminars in liver disease.
[22] D. Thabut,et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors , 2004, Clinical chemistry and laboratory medicine.
[23] V. Paradis,et al. Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.
[24] T. Poynard,et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. , 2003, Journal of hepatology.
[25] M. Manns,et al. Effect of treatment with peginterferon or interferon alfa‐2b and ribavirin on steatosis in patients infected with hepatitis C , 2003, Hepatology.
[26] F. Brancati,et al. The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.
[27] M. Manns,et al. A comparison of fibrosis progression in chronic liver diseases. , 2003, Journal of hepatology.
[28] D. Thabut,et al. A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease , 2002, Comparative hepatology.
[29] C. Day. Pathogenesis of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.
[30] E. Schiff,et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.
[31] Xiao-Hua Zhou,et al. Statistical Methods in Diagnostic Medicine , 2002 .
[32] G Bodemar,et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[33] W Yao,et al. Ultrasonographic texture analysis of parenchymatous organs by the four‐neighborhood‐pixels algorithm: clinical experiment. , 2001, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[34] F. Degos,et al. Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey , 2000, Hepatology.
[35] P. Bedossa,et al. Appropriateness of liver biopsy. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[36] G. Brandi,et al. Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.
[37] B. Neuschwander‐Tetri,et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.
[38] S. Thung,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Liver Pathology and the Metabolic Syndrome X in , 2022 .
[39] M. Bennett,et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver , 1995, The Lancet.
[40] P. Bedossa,et al. Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .
[41] M. Sherman,et al. Post-transplant recurrent hepatitis B viral liver disease. Viral-burden, steatoviral, and fibroviral hepatitis B. , 1992, The American journal of pathology.
[42] D. McClish. Analyzing a Portion of the ROC Curve , 1989, Medical decision making : an international journal of the Society for Medical Decision Making.
[43] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[44] P. Bedossa,et al. Observer variation in assessment of liver biopsies of alcoholic patients. , 1988, Alcoholism, clinical and experimental research.
[45] B. Maharaj,et al. SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.
[46] ThorkildI. A. Sørensen,et al. PROSPECTIVE EVALUATION OF ALCOHOL ABUSE AND ALCOHOLIC LIVER INJURY IN MEN AS PREDICTORS OF DEVELOPMENT OF CIRRHOSIS , 1984, The Lancet.
[47] J. Chaput,et al. [Comparison of the histological lesions in tissue specimens taken from the right and left lobe of the liver in alcoholic liver disease (author's transl)]. , 1979, Gastroenterologie clinique et biologique.
[48] S. Shalhub,et al. The Importance of Routine Liver Biopsy in Diagnosing Nonalcoholic Steatohepatitis in Bariatric Patients , 2004, Obesity surgery.
[49] T. Poynard,et al. 729 Diagnostic value of biochemical markers (fibrotest) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) , 2003 .
[50] J. Bruzzi,et al. Liver biopsy. , 2001, The New England journal of medicine.
[51] Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. , 1994, Hepatology.